New York, NY -- (SBWIRE) -- 01/28/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Hudson City Bancorp, Inc (NASDAQ:HCBK), Gafisa SA (ADR) (NYSE:GFA), Achillion Pharmaceuticals, Inc (NASDAQ:ACHN), MFA Financial, Inc (NYSE:MFA)
Hudson City Bancorp, Inc (NASDAQ:HCBK) showed a volume of 2.85 million shares by the end of last trade whereas the average volume of the stock remained 4.94 million shares. The stock opened the session at $9.03 but then moved to $9.00. At that price, the stock showed a negative performance of -0.50%. Hudson City Bancorp, Inc. (Hudson City Bancorp) serves as the holding company of its subsidiary, Hudson City Savings Bank (the Bank). The Bank is a federal stock savings bank. The Company is a community- and consumer-oriented retail savings bank offering traditional deposit products, residential real estate mortgage loans and consumer loans.
Will HCBK Get Buyers Even After The Recent Rally? Find Out Here
Gafisa SA (ADR) (NYSE:GFA) opened the session at $2.71 and closed the session at $2.69. The stock showed a negative performance of -1.82% in previous trading session. Traded with volume of 2.83 million shares in the prior session and the average volume of the stock remained 1.24 million shares. Gafisa SA is a Brazil-based company engaged in the homebuilding and real estate operations. The Company is involved in the promotion, administration, purchase, sale and trade of real estate properties; provision of financing services to real estate customers; construction and provision of civil engineering services,
Has GFA Found The Bottom And Ready To Gain Momentum? Find Out Here
Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) opened the session at $3.66 and closed the session at $3.44. The stock showed a negative performance of -6.27% in previous trading session. Traded with volume of 2.75 million shares in the prior session and the average volume of the stock remained 2.37 million shares. The beta of the stock remained 0.37. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections.
Why Should Investors Buy ACHN After the Recent Fall? Just Go Here and Find Out
MFA Financial, Inc (NYSE:MFA) the stock decreased -0.28% and finished the session at $7.17. Traded with volume of 2.73 million shares in the prior session and the average volume of the stock remained 3.50 million shares. The beta of the stock remained 0.33. MFA Financial, Inc., is engaged in the business of investing, on a leveraged basis, in residential Agency mortgage-backed securities (MBS) and Non-Agency MBS. Its business objective is to generate net income for distribution to its stockholders resulting from the difference between the interest and other income it earn on its investments and the interest expense it pays on the borrowings,
Will MFA Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)